Interface Q2 sales beat estimates, lifts 2026 outlook
TILE•Q2 results beat estimates
Interface said its second-quarter net sales rose 5.4%, beating analyst expectations.
Adjusted EPS for Q2 rose 46.7% from a year earlier.
| Metric | Beat/Miss | Actual | Consensus Estimate |
|---|---|---|---|
| Q2 Sales | Beat | $395.70 mln | $390.32 mln (4 Analysts) |
| Q2 EPS | $0.88 | ||
| Q2 Net Income | $51.40 mln |
Drivers of margin expansion
The company said higher sales volumes, proactive pricing, favorable mix, and manufacturing efficiencies drove margin growth.
Adjusted gross profit margin benefited from $15.6 mln of IEEPA tariff refunds.
Healthcare billings rose 19%, leading growth among product categories.
Analyst coverage and valuation
The current average analyst rating on the shares is "buy", with 3 "strong buy" or "buy", "hold", and "sell" or "strong sell".
